Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study
- 30 June 1995
- journal article
- Published by Elsevier BV in Urologic Oncology
- Vol. 1 (3), 119-126
- https://doi.org/10.1016/1078-1439(95)00041-f
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladderEuropean Journal of Cancer, 1993
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderThe New England Journal of Medicine, 1991
- Fatal Sepsis Following Intravesical Bacillus Calmette-Guerin Administration for Bladder CancerJournal of Urology, 1990
- A Trial of Prophylactic Thiotepa or Mitomycin C Intravesical Therapy in Patients with Recurrent or Multiple Superficial Bladder CancersJournal of Urology, 1986
- Intravesical Thiotepa and Mitomycin C Treatment Immediately After Transurethral Resection and Later for Superficial (Stages Ta and Tis) Bladder Cancer: A Prospective, Randomized, Stratified Study with Crossover DesignJournal of Urology, 1985
- Designs for group sequential testsControlled Clinical Trials, 1984
- A Phase II Study of lntravesical Mitomycin C in the Treatment of Superficial Bladder CancerBJU International, 1983
- Mitomycin Instillation to Prevent Recurrence of Superficial Bladder CarcinomaEuropean Urology, 1983
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observationJournal of Chronic Diseases, 1981